Ferring Pharmaceuticals to Present New Fertility Data at ASRM 2019 Scientific Congress & Expo
• Ferring will deliver two oral presentations; one showcasing data from MEGASET-HR and the other discussing the influence of body…
// //
• Ferring will deliver two oral presentations; one showcasing data from MEGASET-HR and the other discussing the influence of body…
A comprehensive analysis of 22,300 non-patient individuals, of which 24.4% had nocturia (defined by the study as ≥2 urinations per…
Parsippany, New Jersey – 14 June 2019 – Rebiotix and Ferring Pharmaceuticals were saddened to learn about the patients mentioned…
Sophie Opdyke will be responsible for building Ferring’s new U.S. oncology division, leading its day-to-day operations, and shaping its long-term…
• Ferring acquired exclusive U.S. commercialization rights for generic Ganirelix Acetate Injection for the prevention of premature ovulation in women…
The INVOcell intravaginal culture (IVC) device uses a woman’s own body as a natural incubator during fertilization and early embryo…
NOCDURNA is the first and only sublingual tablet for the treatment of nocturia due to nocturnal polyuria in adults who…
ZOMA-Jet 10 is a new completely needle-free delivery option available for children and adults being treated with the growth hormone,…
Research collaboration aims to uncover new insights into ovarian biology and accelerate the development of personalized interventions in reproductive medicine…
ZOMACTON now approved for 5 pediatric and 1 adult indication Ferring will launch ZOMA-Jet® 10 Needle-Free Delivery System for…